08.01.2015 Views

Guidelines on Diagnosis and Treatment of Malignant Lymphomas

Guidelines on Diagnosis and Treatment of Malignant Lymphomas

Guidelines on Diagnosis and Treatment of Malignant Lymphomas

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Mature T Cell <strong>and</strong><br />

NK Cell Neoplasms<br />

EXTRANODAL NK/T-CELL<br />

LYMPHOMA, NASAL TYPE<br />

Definiti<strong>on</strong> <strong>and</strong> Incidence<br />

Extranodal NK/T cell lymphoma, nasal type is a predominantly<br />

extranodal lymphoma characterised by a broad morphologic<br />

spectrum. The lymphoma typically presents as a locally<br />

destructive proliferative lesi<strong>on</strong>. The disease is most comm<strong>on</strong> in<br />

Asia, Mexico, Central <strong>and</strong> South America. Males predominate<br />

<strong>and</strong> the median age <strong>of</strong> presentati<strong>on</strong> is 50 to 55 years. These<br />

lymphomas have also been described in patients<br />

immunosuppressed following organ transplantati<strong>on</strong>.<br />

ICD-O Code 9719/3<br />

Clinical Presentati<strong>on</strong><br />

The comm<strong>on</strong>est site is the nasal cavity. Identical neoplasms<br />

may be seen in other extranodal sites, including the nasopharynx,<br />

palate, skin, s<strong>of</strong>t tissue, gastrointestinal tract <strong>and</strong> testis. Patients<br />

typically present with facial swelling <strong>and</strong> or mid-line facial<br />

destructi<strong>on</strong> <strong>and</strong> the disease has an aggressive course. It is<br />

localised (stage I <strong>and</strong> II) in 80% at presentati<strong>on</strong> but may<br />

disseminate to the skin, gastrointestinal tract, orbit, CNS or testis.<br />

Pathology <strong>and</strong> Genetics<br />

This lymphoma is described as an angiocentric <strong>and</strong><br />

angiodestructive, proliferative lesi<strong>on</strong>. Fibrinoid changes, coagulative<br />

necrosis <strong>and</strong> apoptotic bodies are comm<strong>on</strong>. There is a broad<br />

spectrum <strong>of</strong> tumour cell morphology. Cells may be small, medium,<br />

large or anaplastic. They may have irregular nuclei which may be<br />

el<strong>on</strong>gated, <strong>and</strong> nucleoli are generally inc<strong>on</strong>spicuous. Mitotic figures<br />

are easily found. There may be a prominent inflammatory infiltrate.<br />

Phenotype<br />

The most comm<strong>on</strong> phenotype is CD2+, CD3-, CD56+, CD7-,<br />

Granzyme +. Other T <strong>and</strong> NK cell antigens are usually negative,<br />

including CD4, CD5, CD8, CD16 <strong>and</strong> CD57.<br />

Genetics<br />

T-Cell receptor <strong>and</strong> immunoglobulin genes are in germline<br />

c<strong>on</strong>figurati<strong>on</strong> in the majority <strong>of</strong> cases, although T-cell receptor<br />

gene rearrangement may be detected. EBV genome is detected in<br />

tumour tissue using in situ hybridizati<strong>on</strong> for EBV-encoded RNA.<br />

Staging<br />

As for other high grade lymphomas.<br />

Recommended Investigati<strong>on</strong>s<br />

As for other high grade lymphomas but should include in<br />

additi<strong>on</strong>: a CT scan <strong>and</strong> MRI <strong>of</strong> nasal sinuses <strong>and</strong> brain.<br />

Lumbar puncture with cytology for malignant cells should<br />

also be performed.<br />

Prognostic Factors / Index<br />

The prognosis is variable, with some patients achieving<br />

complete resp<strong>on</strong>ses to treatment, <strong>and</strong> others dying <strong>of</strong><br />

progressive, disseminated disease. Extranodal involvement in<br />

nasal disease or disease occurring outside the nasal cavity is<br />

very aggressive <strong>and</strong> associated with a short survival.<br />

45

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!